This study evaluated whether renal escape from vasopressin-induced antidiuresis is associated with alterations of vasopressin V 2 receptor binding in the kidney inner medulla. A radioligand binding assay was developed using a novel iodinated vasopressin V 2 receptor antagonist to analyze vasopressin V 2 receptor binding in kidney inner medullary tissue from three groups of rats: normal rats maintained on ad libitum water intake, rats treated with 1-deamino-[8-D-arginine]vasopressin (DDAVP), and rats treated with DDAVP that were also water loaded to induce renal escape from antidiuresis. Analysis of the binding data showed that DDAVP treatment reduced vasopressin V 2 receptor binding to 72% of normal levels. Water loading induced a marked further down-regulation of vasopressin V 2 receptor binding. This receptor down-regulation began by day 2 of water loading, which correlated with the initiation of renal vasopressin escape; by day 3 of water loading, vasopressin V 2 receptor expression fell to 43% of DDAVP-treated levels. No differences in vasopressin V 2 receptor binding affinities were found among the three groups. This study demonstrates that vasopressin V 2 receptor binding capacity is down-regulated during renal escape from vasopressin-induced antidiuresis and suggests that both vasopressin-dependent mechanisms as well as vasopressin-independent mechanisms associated with water loading are involved in this receptor down-regulation. (Endocrinology 141: [307][308][309][310][311][312][313][314] 2000) A RGININE VASOPRESSIN (AVP) is the major physiological regulator of renal water excretion. AVP acts on vasopressin V 2 receptors in the kidney and increases the water permeability of the renal distal tubules and collecting ducts, thereby accelerating water absorption. However, during some physiological and clinical circumstances, the renal ability to concentrate urine in response to AVP is decreased. In humans and animals, sustained administration of AVP and water results in water retention with progressive hyponatremia for several days, which is then followed by varying degrees of escape from the vasopressin-induced antidiuresis. With the onset of vasopressin escape, water excretion increases despite the sustained administration of AVP, thus allowing reestablishment of water balance with stabilization of the serum sodium level. The renal vasopressin escape phenomenon has been studied experimentally in various animal models of sustained antidiuresis (1-4). However, the mechanisms responsible for renal vasopressin escape remain incompletely understood.
A RGININE VASOPRESSIN (AVP) is the major physiological regulator of renal water excretion. AVP acts on vasopressin V 2 receptors in the kidney and increases the water permeability of the renal distal tubules and collecting ducts, thereby accelerating water absorption. However, during some physiological and clinical circumstances, the renal ability to concentrate urine in response to AVP is decreased. In humans and animals, sustained administration of AVP and water results in water retention with progressive hyponatremia for several days, which is then followed by varying degrees of escape from the vasopressin-induced antidiuresis. With the onset of vasopressin escape, water excretion increases despite the sustained administration of AVP, thus allowing reestablishment of water balance with stabilization of the serum sodium level. The renal vasopressin escape phenomenon has been studied experimentally in various animal models of sustained antidiuresis (1) (2) (3) (4) . However, the mechanisms responsible for renal vasopressin escape remain incompletely understood.
Vasopressin V 2 receptors belong to the seven-transmembrane domain, G protein-coupled receptor superfamily and are mainly present in the renal distal tubules and collecting ducts (5) . Activation of vasopressin V 2 receptor leads to an increase in intracellular cAMP by stimulating adenylate cyclase activity through G s . AVP regulates the water permeability of renal collecting tubule cells in two ways. Short term regulation is achieved by shuttling of aquaporin-2 water channels from intracellular vesicles into the apical plasma membrane (6) . Long-term regulation occurs through increasing the abundance of aquaporin-2 protein (7) by the action of cAMP response element-binding protein on the cAMP response element in the 5Ј-flanking region of the aquaporin-2 gene (8) . Recent studies from our laboratories have demonstrated that renal vasopressin escape from AVP-induced antidiuresis is accompanied by marked down-regulation of kidney aquaporin-2 protein and messenger RNA (mRNA) expression (9) . Additional studies of isolated perfused collecting tubules from animals undergoing escape from antidiuresis have shown a reduced ability to generate cAMP in response to vasopressin stimulation (10) . As renal aquaporin-2 protein expression and distribution are mainly regulated by AVP via vasopressin V 2 receptor-stimulated adenylate cyclase activation in the kidney, we hypothesized that altered function of inner medullary V 2 receptors may contribute to renal vasopressin escape by decreasing cAMP generation and its subsequent effects on aquaporin-2 expression and function. Accordingly, this study was designed to examine whether altered vasopressin V 2 receptor binding capacity and/or affinity are associated with the renal vasopressin escape phenomenon in an experimental model of inappropriate antidiuresis in the rat (11) .
Because iodination of the tyrosine residue in the pressin ring of AVP interferes with binding to V 2 receptors, it has been difficult to perform vasopressin V 2 receptor binding studies in kidney inner medulla due to the lack of a suitable radioligand with high specific activity (12, 13) . In this report we describe the development of a radioligand binding assay using a novel iodinated V 2 -selective receptor antagonist with high specific activity to study the vasopressin V 2 receptor during renal vasopressin escape. Our results demonstrate that vasopressin V 2 receptor binding is markedly decreased during experimental renal vasopressin escape, and that this V 2 receptor down-regulation correlates well with the initiation of renal escape from AVP-induced antidiuresis.
Materials and Methods

Animal protocol
Male Sprague Dawley rats, weighing 300 -350 g, were used in these studies. The renal escape animal model was induced using methods previously characterized by our laboratory (11) . Three groups of rats were studied. The first group consisted of normal rats maintained with ad libitum water and pelleted rat chow. The other two groups were implanted sc with osmotic minipumps (Alzet model 2002, Alza Corp., Palo Alto, CA) that delivered 5 ng/h of the V 2 receptor selective agonist 1-deamino- [8-d-arginine] vasopressin (DDAVP; Rhone-Poulenc Rorer, Collegeville, PA). After 4 days of DDAVP administration to create maximal sustained antidiuresis, the second group (DDAVP-control) continued to receive DDAVP and were maintained on ad libitum water and pelleted rat chow, whereas the third group (DDAVP-water loaded) continued to receive DDAVP but were induced to drink excess water by substituting daily feedings of a liquid formula (AIN-76, BioServ, Frenchtown, NJ). All rats were maintained in metabolic cages, allowing quantitative urine collections for daily measurement of urine volume and osmolality.
Preparation of kidney inner medullary membranes
Animals were killed by decapitation, and blood samples were collected for measurement of the plasma sodium concentration. Kidneys were quickly removed and rinsed with ice-cold buffer A (50 mm TrisHCl/1.0 mm EDTA solution, freshly added 1.0 g/ml bacitracin, 0.2 g/ml aprotinin, and 1.0 g/ml leupeptin, pH 7.5) and were then sliced along the corticomedullary axis to separate the medulla from the cortex. The inner medullary region of the kidneys was dissected and minced in ice-cold buffer A. The inner medulla was homogenized with 10 strokes in a glass homogenizer (Thomas; Swedesboro, NJ) on ice. The resulting homogenate was centrifuged at 1,000 ϫ g for 10 min at 4 C. The pellet was discarded, and the supernatant was recentrifuged in ice-cold buffer A at 15,000 ϫ g for 30 min at 4 C. The membrane preparations were gently vortexed and resuspended in ice-cold buffer A to final concentrations of 0.5-1.0 mg protein/ml and were immediately stored at Ϫ80 C. Approximately 0.6 -0.7 mg protein can be obtained from the inner medulla of one rat kidney. Membrane protein concentrations were determined by protein assay using BSA as the standard (Bio-Rad Laboratories, Inc., Richmond, CA).
Preparation of vasopressin V 2 radioligand
Quantitation of vasopressin V 2 receptors in past studies has been hampered by the lack of ideal radioactive ligands; iodination of the tyrosine residue in the AVP pressin ring abolishes ligand binding, and tritiated AVP has low specific activity. Recently, novel selective V 2 receptor antagonists have been developed that retain surprisingly high anti-V 2 potency by modifying AVP at position 2 (14) . In initial experiments, we chose a position 2-modified V 2 antagonist, d(CH 2 ) 5 [dIle 2 ,Ile 4 ,Tyr-NH 2 9 ]AVP, which has been shown to be relatively selective for vasopressin V 2 receptors and has a tyrosine iodination site at the carboxyl-terminal distant from the ligand-receptor binding site where an isoleucine has replaced the normal tyrosine residue (courtesy of Dr. Maurice Manning, Medical College of Ohio, Toledo, OH). This ligand was iodinated using the chloramine-T method (15) , and the monoiodinated V 2 antagonist was purified by reverse phase (C 18 ) HPLC. Preliminary studies using this iodinated radioligand ([ 125 I]V2RA) were performed to determine the optimal conditions for binding to rat kidney inner medullary membranes.
Vasopressin V 2 receptor binding assay
Membrane preparations (20 -25 g protein) were suspended in 300 l buffer B (buffer A supplemented with 0.1% BSA, pH 7.5) at 0 -4 C. For saturation studies, samples were incubated for 50 min at 27 C with concentrations of [ 125 I]V2RA ranging from 10 -800 pm. The binding reaction was terminated by rapid filtration through Whatman GF/C glass fiber filters (Clifton, NJ) after the addition of 3 ml ice-cold PBS buffer. Bound tracer was rapidly separated from unbound tracer by washing filters four times with ice-cold PBS using a Brandel vacuum harvester (model M-24, Gaithersburg, MD). Radioactivity was measured in a ␥-counter (Cobra, Packard, Downers Grove, IL). Nonspecific binding was determined in the presence of 1 m unlabeled DDAVP. Preincubation of glass-fiber filters with 10% BSA overnight was used to reduce nonspecific absorption of the radioligand to the filters. Specific binding was calculated as the difference between total binding and nonspecific binding. Vasopressin V 2 receptor binding density (B max ) and affinity (K d ) were analyzed by Scatchard analysis using a nonlinear program of PRISM (GraphPad Software, Inc., San Diego, CA).
Statistical analysis
All results are expressed as the mean Ϯ sem, and differences between groups were analyzed statistically using one-way ANOVA followed by post-hoc comparisons via the Student-Newman-Keuls test.
Results
Binding characteristics of [ 125 I]V2RA to rat kidney inner medulla membranes
In initial experiments, we used [
125 I]V2RA to determine the optimal conditions for binding to rat kidney inner medullary membranes. Due to the hydrophilic nature of the ligand, nonspecific binding represented a significant problem. To decrease nonspecific binding, we compared the following conditions: 1) concentration of BSA in the binding reaction buffer (from 0 -0.3% BSA), 2) type of binding reaction tube (polystyrene tube and borosilicate glass tube), 3) filter paper (Whatman GF/B and GF/C glass fiber filters), and 4) pretreatment of filter (with polyethylenimine (0.3%) and BSA from 1-10%). Four of these factors were found to be critical in reducing nonspecific binding. These included the inclusion of 0.1% BSA in the binding reaction buffer, the choice of borosilicate glass tube for the binding reaction, the use of GF/C glass-fiber filters for separation of bound from free tracer, and pretreatment of the filters overnight with 10% BSA. Under these conditions, total [
125 I]V2RA binding to rat inner medullary was less than 10% of the total ligand concentration in the binding assay. As the free concentration of radioligand was approximately equal to the concentration added, ligand depletion was negligible during the binding reaction. The binding assay followed the law of mass action ( A time course of [ 125 I]V2RA binding to rat kidney inner medullary membranes at 27 C revealed that maximal specific binding was reached after 30 min and was stable thereafter for up to 60 min ( Fig. 2A) . Incubation of increasing concentrations of membrane protein ranging from 15-30 g with 500 pm [
125 I]V2RA showed that [ 125 I]V2RA specific binding to kidney inner medulla membranes was linearly related to the protein concentration under these conditions (Fig. 2B) . Consequently, all further binding experiments were per-formed at 27 C using 20 -25 g membrane protein/sample, and the duration of the binding reaction in the presence of [ 125 I]V2RA was 50 min unless otherwise described.
Saturation curves from 10 -800 pm [ 125 I]V2RA revealed a saturable and single population of high affinity vasopressin V 2 receptors in the rat kidney inner medulla (Fig. 3A) . Scatchard analysis of the data indicated a B max of 240 Ϯ 12 fmol/mg protein (n ϭ 8), and an apparent K d of 0.24 Ϯ 0.04 nm (n ϭ 8) in normal rat kidney inner medullary membranes (Fig. 3B ). This is consistent with reported values from binding studies, using a similar iodinated agonist performed on rat vasopressin V 2 receptors expressed in COS-7 cells (16) .
Effect of elevated DDAVP in plasma on vasopressin V 2 receptor binding
Previous studies suggested that elevated AVP in plasma results in decreased vasopressin V 2 receptor binding density in the rat kidney medulla (17, 18) . Our laboratory demonstrated that no significant differences exist between systemic infusion of AVP and DDAVP with regard to the degree of hyponatremia produced, the induced brain edema, adaptive losses of brain electrolytes, or the incidence of morbidity and mortality from neurological deficits (19) . To evaluate whether elevated DDAVP in plasma down-regulates vasopressin V 2 receptor binding similarly to AVP, we compared vasopressin V 2 receptor binding between normal untreated rats and rats that received a DDAVP infusion continuously for 5, 6, and 7 days, respectively. The normal untreated rats were maintained on ad libitum water and pelleted rat chow. The DDAVP infusion rats were implanted sc with osmotic minipumps that delivered DDAVP at 5 ng/h and were then maintained with ad libitum water and pelleted rat chow until decapitation. As expected, vasopressin V 2 receptor binding was significantly reduced to 72% of normal levels after 5 days of DDAVP infusion (n ϭ 8; P Ͻ 0.05). Longer periods of DDAVP infusion, from 6 -7 days, caused no further downregulation of vasopressin V 2 receptor binding (Fig. 4) . No significant differences in V 2 receptor binding affinity were found between untreated and DDAVP-infused rats (K d : untreated rats, 0.24 Ϯ 0.04 nm; 5-day DDAVP infusion, 0.36 Ϯ 0.05 nm; 6-day DDAVP infusion, 0.34 Ϯ 0.05 nm; 7-day DDAVP infusion, 0.37 Ϯ 0.06 nm; all P Ͼ 0.05).
Time course of renal vasopressin escape
For induction of renal vasopressin escape, rats were implanted with DDAVP-containing minipumps (5 ng/h) and then maintained according to the animal protocol described in Materials and Methods. After 4 days of DDAVP infusion and ad libitum intake of water and pelleted rat chow, DDAVPcontrol rats were continually maintained with ad libitum water and pelleted rat chow, whereas DDAVP-water loaded rats were switched to a liquid diet. In response to their hunger drive, the DDAVP-water loaded rats ingested excess water daily, which resulted in extracellular fluid dilution and hyponatremia. Table 1 summarizes the physiological data obtained from DDAVP-control and DDAVP-water loaded rats. The data show that the plasma sodium concentration significantly decreased in DDAVP-water loaded rats compared with the DDAVP-control rats on the first day of water loading, reflecting a significant degree of water retention induced by the DDAVP antidiuresis. By the second day of water loading, urine volume increased, and urinary osmolality decreased significantly in the DDAVP-water loaded rats compared with the DDAVP-control rats despite ongoing DDAVP infusions, indicating the onset of renal escape from the DDAVP-induced antidiuresis.
Effect of water loading on vasopressin V 2 receptor binding
To address whether water loading caused an additional regulation of vasopressin V 2 receptor function, we analyzed vasopressin V 2 receptor binding in inner medullary membranes from DDAVP-control rats and DDAVP-water loaded rats. The difference in vasopressin V 2 receptor binding between the DDAVP-control rats and the DDAVP-water loaded rats represents the additional down-regulation of vasopressin V 2 receptors induced by water loading. Table 2 summarizes the vasopressin V 2 receptor binding densities and affinities from the two experimental groups of rats on each day of the water loading. The data show that by day 1 of water loading, no difference in vasopressin V 2 receptor binding was found between the DDAVP-control rats and the DDAVP-water loaded rats (n ϭ 8; P Ͼ 0.05), but by the second day of water loading, vasopressin V 2 receptor binding fell to 77% of that in DDAVP-control rats (n ϭ 12, P Ͻ 0.05), and by the third day of water loading, vasopressin V 2 receptor binding decreased to 43% of that in DDAVP-control rats (n ϭ 10, P Ͻ 0.01). These results indicate that water loading can further down-regulate the vasopressin V 2 receptor and also suggest that DDAVP-independent factors probably play a significant role in renal escape with prolonged water loading. No significant difference in vasopressin V 2 receptor affinity (K d ) was observed between DDAVPcontrol rats and DDAVP-water loaded rats (P Ͼ 0.05). Figure 5 compares the time courses of urine water excretion changes and down-regulation of vasopressin V 2 receptor expression. Figure 5A shows that urine volume significantly increased by the second day of the water loading, which indicates the onset of the escape response. Figure 5B shows 
FIG. 4.
Vasopressin V 2 receptor binding density in rat kidney medullary membranes from untreated rats and DDAVP-infused rats. The normal untreated rats were maintained on ad libitum water and pelleted rat chow. The DDAVP-infused rats were implanted sc with osmotic minipumps that delivered DDAVP at 5 ng/h and were then maintained with ad libitum water and pelleted rat chow for 5-7 days. Binding assays were carried out as described in Materials and Methods. Bars represent the mean Ϯ SEM of V 2 receptor binding (B max ) from different groups of rats. *, P Ͻ 0.05 compared with untreated rats.
that the down-regulation of vasopressin V 2 receptor expression also started by the second day of water loading. These results indicate that the down-regulation of vasopressin V 2 receptors correlates temporally with the onset of renal vasopressin escape. Figure 6 compares the vasopressin V 2 receptor binding among the normal untreated rats, the DDAVP-control rats, and the DDAVP-water loaded rats (after 3 days of water loading). From these data, it is clear that the elevated DDAVP in plasma significantly reduced vasopressin V 2 receptor binding, and that water loading induced a further significant down-regulation of vasopressin V 2 receptor binding.
Discussion
The phenomenon of renal escape from vasopressin-induced antidiuresis is an important adaptive mechanism to maintain body water balance during conditions of high plasma AVP. Although this phenomenon has been reported in humans, rats, and dogs (1-4), the mechanisms responsible for renal vasopressin escape remain poorly understood. Given recent findings suggesting decreased cAMP generation in response to vasopressin stimulation in perfused collecting tubules from animals undergoing escape (10), it is appropriate to consider the possibility that altered vasopressin V 2 receptor function could be responsible for alterations in adenylate cyclase activity and subsequent aquaporin-2 expression under these conditions. In the present study we used an animal model previously characterized by our laboratory (11) to study the relationship between the phenomenon of renal vasopressin escape and regulation of kidney vasopressin V 2 receptor expression. The results of our study demonstrate that renal vasopressin escape is indeed associated with a marked down-regulation of vasopressin V 2 receptor binding in the kidney inner medulla.
To perform these studies, we first developed an assay using a novel iodinated V 2 selective receptor antagonist (20) with high specific activity to perform vasopressin V 2 receptor binding measurements in rat kidney inner medulla. As iodination of the tyrosine residue in the pressin ring of AVP abolishes binding to the vasopressin V 2 receptor in the kidney, tritiated vasopressin with low specific activity has been the only radioligand available for renal vasopressin V 2 receptor binding studies for many years. The low specific activity binding efficiency of the tritiated vasopressin has hampered vasopressin V 2 receptor studies, especially when limited sample sources from small animal models have to be used. For example, at least 100 -300 g membrane protein/ sample is necessary for binding analysis when using tritiated AVP in the rat kidney medulla (21, 22) . Therefore, to obtain sufficient kidney medulla membranes for one saturation Scatchard analysis, kidneys from at least three to five animals have to be pooled. Recently, some 125 I-and 35 S-labeled vasopressin analogs have been developed for receptor binding studies; however, the majority of these ligands are either V 1 receptor selective, or they have high binding affinities to both V 1 and V 2 receptors (12, 13, 20) . Another limitation is that some of these iodinated ligands (e.g. N-[
125 I]l-Tyr-[Lys 8 ]vasopressin) are very unstable and degrade to such an extent during the incubation period that no specific binding is detectable at 37 C (13) .
In the present study we developed a binding assay for the high specific activity V 2 selective antagonist [ 125 I]V2RA to quantitate vasopressin V 2 receptor function. Under the assay conditions employed, only 20 -25 g membrane protein/ sample was needed for vasopressin V 2 receptor analysis. Thus, only one or two rats are required per saturation curve using [
125 I]V2RA compared with three to five rats using a tritiated ligand. Under these assay conditions, the binding of [ 125 I]V2RA to rat kidney inner medulla membranes was shown to be rapid, saturable, dependent on the membrane protein concentration, and less than 10% of the total radiolabeled ligand concentration was bound. Thus, radioligand binding assay conditions were developed that meet the criteria necessary for determination of B max and K d Scatchard analysis. Saturation curves from 10 -800 pm [
125 I]V2RA revealed a single population of high affinity V 2 receptors in rat Our studies show that vasopressin V 2 receptor binding expression in kidney inner medulla is down-regulated during renal escape from DDAVP-induced antidiuresis. Previous work reported that alterations of renal concentrating ability are associated with down-regulation of vasopressin V 2 receptors under some physiological and pathophysiological circumstances (17, 18) . For example, rats in chronic renal failure exhibit a marked decrease in vasopressin V 2 receptor density and the virtual absence of V 2 receptor mRNA without changes in other G protein-coupled receptors. Based on these findings, it has been proposed that vasopressin resistance in chronic renal failure is due at least in part to a selective down-regulation of vasopressin V 2 receptors as a consequence of decreased V 2 receptor mRNA expression (18) . Another example is dehydration. When AVP levels in plasma are elevated by 72 h of water deprivation, the vasopressin V 2 receptor density (B max ) in renal tubular epithelial basolateral cells is reduced by 38% without affecting the affinity (K d ) of the receptor (17) . This phenomenon seems somewhat paradoxical, as vasopressin V 2 receptor density was reduced in animals that needed more water conservation. One potential explanation for this phenomenon is that the kidney may possess spare V 2 receptors (17, (23) (24) (25) , such that larger decreases in receptor density are required before second messenger levels (in this case cAMP) are affected. Decreases in vasopressin V 2 receptor density also have been observed in aged rats. However, the data regarding the likely cause of vasopressin V 2 receptor down-regulation with aging are contradictory (21, 22) . Some investigators have found that aging is accompanied by a tendency toward a reduction in plasma AVP levels; however, other investigators did not find a significant difference in vasopressin levels between young and old rats (22) . These opposing observations can be explained by the different experimental models employed, but also suggest the possibility that the down-regulation of vasopressin V 2 receptors may occur via more than one mechanism.
The present study indicates that elevated DDAVP in plasma is partially responsible for the down-regulation of the V 2 receptor in the kidney inner medulla during the escape process. After 5 days of DDAVP infusion, vasopressin V 2 receptor binding was decreased to 72% of that in normal untreated rats. Prolongation of the DDAVP infusion from 5 FIG. 5. Time courses of urine excretion changes and vasopressin V 2 receptor down-regulation. All rats were implanted with DDAVP minipumps on day Ϫ4 and received ad libitum water and pelleted rat chow. On day 0, one group was switched to the liquid diet (DDAVPwater loaded), and the other group continued to receive ad libitum water and pelleted rat chow (DDAVP-control). A, Urine excretion. Rats were maintained in metabolic cages allowing collection of urine daily. The DDAVP-water loaded rats first showed evidence of escape on day 2. B, Vasopressin V 2 receptor binding. Rats were euthanized for V 2 receptor binding analysis following the animal protocol. Binding assays were carried out as described in Materials and Methods. The down-regulation of V 2 receptors started on day 2. Data are expressed as the mean Ϯ SEM from 8 -12 rats in each group. *, P Ͻ 0.05 compared with DDAVP-control rats.
FIG. 6.
Comparison of vasopressin V 2 receptor binding saturation curves from untreated, DDAVP-control and DDAVP-water loaded rats. Rats were maintained according to the animal protocol. Binding assays were carried out as described in Materials and Methods and were analyzed using a nonlinear program of PRISM. Saturation curves for each group are representative of four independent experiments performed in duplicate.
to 7 days did not induce further decreases in vasopressin V 2 receptor binding, suggesting that the down-regulation induced by elevated DDAVP occurred over a limited time period and did not progress after prolonged DDAVP exposure. The vasopressin V 2 receptor is a member of the seventransmembrane domain, G protein-coupled receptor superfamily. Although agonist-induced receptor down-regulation has been reported in a number of G protein-coupled receptors (26) , the mechanisms of agonist-induced receptor downregulation have not been well studied for vasopressin V 2 receptors. Ligand-induced internalization of the V 2 and V 1a receptors via coated pits was demonstrated in pig tubular epithelial cells and rat smooth muscle cells, respectively (27, 28) . As observed for other G protein-coupled receptors, receptor internalization only occurred in response to agonist, but not antagonist, binding. These findings suggest that internalization depends on receptor activation of intracellular signaling pathways.
The lateral mobility of agonist-receptor complexes in the plasma membrane lipid bilayer is also an important determinant in G protein-coupled receptor signaling (e.g. activation of adenylate cyclase) (29) . After incubation of medullary tubules with AVP for 4 h, 82% of specific bound receptor was internalized by the cells (30) . After removing the AVP, most (90 Ϯ 6%) of the internalized receptor recycled back to the surface. This agonist-induced vasopressin V 2 receptor internalization and recycling are not dependent on receptor protein resynthesis (30) . In our experiments, rats were continuously infused with DDAVP for 5-7 days. This extended period of DDAVP stimulation may have caused increased receptor internalization and abnormal recycling of the vasopressin V 2 receptor. An alternative explanation is that elevated plasma DDAVP induced a decrease in V 2 receptor mRNA expression. Firsov reported that in vivo administration of DDAVP induced a selective down-regulation of V 2 receptor mRNA expression by 50% but without changing V 1a receptor mRNA expression (31) .
The present study also indicates that DDAVP-independent mechanisms associated with water loading are involved in down-regulation of vasopressin V 2 receptor function. Our animal model enabled us to compare the time course of changes in urine volume and in vasopressin V 2 receptor binding to determine whether the regulation of V 2 receptor binding coincided with the onset of the escape as indicated by increases in urine volume. Figure 5 shows that the time course of vasopressin V 2 receptor down-regulation coincides with the initiation of the renal escape from DDAVP-induced antidiuresis. Perhaps the most significant finding of this study is that DDAVP-independent mechanisms may be more responsible for the renal vasopressin escape phenomenon. The differences in vasopressin V 2 receptor binding between the DDAVP-control rats and DDAVP-water loaded rats represents the down-regulation of vasopressin V 2 receptor expression induced by DDAVP-independent factors. As shown in Table 2 , vasopressin V 2 receptor binding in DDAVP-water loaded rats fell to 77% of that in DDAVP-control rats (n ϭ 12; P Ͻ 0.05) by day 2 of water loading, and by the third day of water loading, vasopressin V 2 receptor binding decreased further to 43% of the DDAVP-control level (n ϭ 10; P Ͻ 0.01). This finding therefore suggests that DDAVP-independent factors are important in renal vasopressin escape with the continued water loading. These findings are also consistent with recent studies demonstrating that vasopressin V 2 receptors can be regulated by AVP-independent factors. Lithium significantly decreased V 2 receptor binding in rat renal papillary collecting duct membranes without significantly altering plasma AVP levels (32), consistent with earlier studies showing that lithium down-regulated AVP-stimulated cAMP generation in cultured rat inner medullary collecting tubule cells (33) . Similarly, oral administration of chlorpropamide increased the density of AVP V 2 receptors in rat renal papilla tissue without changing plasma AVP levels (34) .
If down-regulation of V 2 receptor binding is in part responsible for renal escape from antidiuresis by decreasing cAMP levels in medullary collecting duct cells, thereby decreasing both the synthesis and the membrane insertion of aquaporin-2 water channels, then it might be asked why the DDAVP down-regulation of receptor binding itself does not cause a similar process. Two explanations are possible to explain the lack of this observed effect. First, the collecting tubule cells may possess spare receptors (17, (23) (24) (25) , as discussed previously, such that larger decreases in receptor binding are necessary to impact upon coupled adenylate cyclase activity and cAMP levels. Second, the antidiuresis caused by DDAVP may indeed be submaximal as a result of the induced down-regulation of receptor function, but this would not be seen as an escape from the DDAVP-induced antidiuresis if it occurred very rapidly. Both these and other possibilities will require further study using in vitro expression of V 2 receptors Finally, if down-regulation of vasopressin V 2 receptor binding is indeed causally related to the observed escape from vasopressin-induced antidiuresis, then it would be appropriate to consider potential mechanisms underlying this down-regulation. One obvious possibility is that local changes in plasma or tissue osmolality might be sufficient to cause mechanical perturbations of the basolateral membranes of collecting duct cells, which could, in turn, affect receptor dimerization or receptor internalization and recycling, as discussed previously for the agonist-stimulated down-regulation. However, recent studies have not supported an important role for either plasma or tissue osmolality in the escape process (35) . Alternatively, the decreased receptor binding might reflect a true decrease in receptor number mediated either by down-regulated receptor synthesis or up-regulated receptor degradation. Recent studies of kidney AVP V 2 mRNA expression have supported the former possibility (36) . In this case further studies will be necessary to identify the signal(s) responsible for down-regulation of AVP V 2 receptor synthesis. These will probably include humoral and/or hemodynamic factors that reflect expansion of the extracellular fluid volume, as this is well known to be critical for the production of escape from antidiuresis (1-4) .
In summary, we have used a new radioligand to quantitate vasopressin V 2 receptor binding in the kidney. Using these methods, we have confirmed that elevated AVP in plasma causes vasopressin V 2 receptor down-regulation in the kidney, but also that DDAVP-independent mechanisms related to water loading cause further vasopressin V 2 receptor down-regulation during escape from vasopressin-induced antidiuresis. Thus, we have demonstrated for the first time that vasopressin V 2 receptors in the rat kidney inner medulla are markedly down-regulated during escape from vasopressin-induced antidiuresis. Although these findings do not prove that the measured changes in V 2 binding are causally related to renal escape from the effects of vasopressin, the strong temporal correlation between the receptor down-regulation and the initiation of physiological renal escape is consistent with this hypothesis. It is tempting to speculate that similar changes in receptor binding and transporter function might underlie other physiological escape processes as well, such as escape from excess mineralocorticoids, but this possibility must await future studies of receptor binding and expression and/or transporter expression specific to each situation.
